Literature DB >> 8606064

A recombinant protein based on the Trypanosoma cruzi metacyclic trypomastigote 82-kilodalton antigen that induces and effective immune response to acute infection.

R Santori F1, G S Paranhos-Bacalla, J Franco DA Silveira, L M Yamauchi, J E Araya, N Yoshida.   

Abstract

To further investigate the immunological properties of the stage-specific 82-kDa glycoprotein (gp82) of Trypanosoma cruzi metacyclic trypomastigotes, previously shown to induce antigen-specific humoral and T-cell responses in mice, we performed a series of experiments with recombinant proteins containing sequences of gp82 fused to glutathione S-transferase. Of five fusion proteins tested, only J18b and J18b1, the carboxyproximal peptides containing amino acids 224 to 516 and 303 to 516, respectively, were recognized by monoclonal antibody 3F6 as well as by various anti-T. cruzi antisera and, when administered to mice, were capable of eliciting antibodies directed to the native gp82. The amino-terminal peptide and other carboxyterminal recombinant proteins lacking the central domain of gp82 (amino acids 224 to 356), which is exposed on the surface of live metacyclic forms, did not display any of these properties. Spleen cells derived from mice immunized with any of the five recombinant proteins proliferated in vitro in the presence of native gp82.J18b was the most stimulatory, whereas J18b3, the peptide containing amino acids 408 to 516, elicited the weakest response. When BALB/c mice immunized with J18b antigen plus A1(OH)3 as adjuvant were challenged 10 5 metacyclic trypomastigotes, 85% of them resisted acute infection, in comparison with control mice that received glutathione S-transferase plus adjuvant. Antibodies induced by J18b protein lacked agglutinating or complement-dependent lytic activity and failed to neutralize parasite infectivity. On the other hand, CD4+T cells from the spleens of J18b-immunized mice displayed an intense proliferative activity upon stimulation with 1.25 microgram of native gp82 per ml, which resulted in increased production of gamma interferon, a cytokine associated with resistance to T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8606064      PMCID: PMC173889          DOI: 10.1128/iai.64.4.1093-1099.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  An 85-kilodalton surface antigen gene family of Trypanosoma cruzi encodes polypeptides homologous to bacterial neuraminidases.

Authors:  G B Takle; G A Cross
Journal:  Mol Biochem Parasitol       Date:  1991-10       Impact factor: 1.759

2.  Cloning of a major surface-antigen gene of Trypanosoma cruzi and identification of a nonapeptide repeat.

Authors:  D S Peterson; R A Wrightsman; J E Manning
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

3.  Trypanosoma cruzi: recognition of trypomastigote surface antigens by lytic antisera from mice resistant to acute infection.

Authors:  N Yoshida
Journal:  Exp Parasitol       Date:  1986-04       Impact factor: 2.011

4.  Evidence implicating L3T4 in class II MHC antigen reactivity; monoclonal antibody GK1.5 (anti-L3T4a) blocks class II MHC antigen-specific proliferation, release of lymphokines, and binding by cloned murine helper T lymphocyte lines.

Authors:  D B Wilde; P Marrack; J Kappler; D P Dialynas; F W Fitch
Journal:  J Immunol       Date:  1983-11       Impact factor: 5.422

5.  Surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi.

Authors:  N Yoshida
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

6.  Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi.

Authors:  M J Alves; G Abuin; V Y Kuwajima; W Colli
Journal:  Mol Biochem Parasitol       Date:  1986-10       Impact factor: 1.759

7.  Inhibition of murine T cell-mediated cytolysis and T cell proliferation by a rat monoclonal antibody immunoprecipitating two lymphoid cell surface polypeptides of 94 000 and 180 000 molecular weight.

Authors:  M Pierres; C Goridis; P Golstein
Journal:  Eur J Immunol       Date:  1982-01       Impact factor: 5.532

8.  Stage-specific surface antigens of metacyclic trypomastigotes of Trypanosoma cruzi identified by monoclonal antibodies.

Authors:  M M Teixeira; N Yoshida
Journal:  Mol Biochem Parasitol       Date:  1986-03       Impact factor: 1.759

9.  The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta.

Authors:  R T Gazzinelli; I P Oswald; S Hieny; S L James; A Sher
Journal:  Eur J Immunol       Date:  1992-10       Impact factor: 5.532

10.  Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas' disease patients.

Authors:  Y A Skeiky; D R Benson; M Parsons; K B Elkon; S G Reed
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

View more
  11 in total

1.  Humoral and cellular immune responses in BALB/c and C57BL/6 mice immunized with cytoplasmic (CRA) and flagellar (FRA) recombinant repetitive antigens, in acute experimental Trypanosoma cruzi infection.

Authors:  Valéria R A Pereira; Virginia M B Lorena; Mineo Nakazawa; Carlos F Luna; Edimilson D Silva; Antonio G P Ferreira; Marco Aurélio Krieger; Samuel Goldenberg; Milena B P Soares; Eridan M Coutinho; Rodrigo Correa-Oliveira; Yara M Gomes
Journal:  Parasitol Res       Date:  2005-04-27       Impact factor: 2.289

2.  The YopB protein of Yersinia pseudotuberculosis is essential for the translocation of Yop effector proteins across the target cell plasma membrane and displays a contact-dependent membrane disrupting activity.

Authors:  S Håkansson; K Schesser; C Persson; E E Galyov; R Rosqvist; F Homblé; H Wolf-Watz
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

3.  Role of GP82 in the selective binding to gastric mucin during oral infection with Trypanosoma cruzi.

Authors:  Daniela I Staquicini; Rafael M Martins; Silene Macedo; Gisela R S Sasso; Vanessa D Atayde; Maria A Juliano; Nobuko Yoshida
Journal:  PLoS Negl Trop Dis       Date:  2010-03-02

4.  Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection.

Authors:  Christopher S Eickhoff; Olivia K Giddings; Nobuko Yoshida; Daniel F Hoft
Journal:  Mem Inst Oswaldo Cruz       Date:  2010-08       Impact factor: 2.743

5.  Targeted reduction in expression of Trypanosoma cruzi surface glycoprotein gp90 increases parasite infectivity.

Authors:  S Málaga; N Yoshida
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.

Authors:  Eric Dumonteil; Javier Escobedo-Ortegon; Norma Reyes-Rodriguez; Arletty Arjona-Torres; Maria Jesus Ramirez-Sierra
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

7.  Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.

Authors:  Shivali Gupta; Nisha Jain Garg
Journal:  PLoS Negl Trop Dis       Date:  2010-08-10

8.  Involvement of Trypanosoma cruzi metacyclic trypomastigote surface molecule gp82 in adhesion to gastric mucin and invasion of epithelial cells.

Authors:  Ivan Neira; Fernando A Silva; Mauro Cortez; Nobuko Yoshida
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

9.  Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.

Authors:  Vandanajay Bhatia; Nisha Jain Garg
Journal:  Clin Vaccine Immunol       Date:  2008-06-11

10.  Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.

Authors:  Christopher S Eickhoff; Jose R Vasconcelos; Nicole L Sullivan; Azra Blazevic; Oscar Bruna-Romero; Mauricio M Rodrigues; Daniel F Hoft
Journal:  PLoS Negl Trop Dis       Date:  2011-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.